Quantification, radiomics and artificial intelligence in infection imaging: Current status and future directions in nuclear medicine

IF 6.6 2区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Seminars in nuclear medicine Pub Date : 2026-05-01 Epub Date: 2026-03-13 DOI:10.1053/j.semnuclmed.2026.02.002
Geoffrey M. Currie , Dale L. Bailey
{"title":"Quantification, radiomics and artificial intelligence in infection imaging: Current status and future directions in nuclear medicine","authors":"Geoffrey M. Currie ,&nbsp;Dale L. Bailey","doi":"10.1053/j.semnuclmed.2026.02.002","DOIUrl":null,"url":null,"abstract":"<div><div>Nuclear medicine infection imaging has traditionally relied on semantic visual interpretation supported by simple semi-quantitative indices. While effective, this paradigm is limited by observer dependence, restricted sensitivity to subtle or diffuse disease, and difficulty in standardising interpretation across centres. Advances in quantitative imaging, radiomics and artificial intelligence (AI) are reshaping this landscape. These complementary domains, collectively conceptualised as <em>computomics</em>, extend infection imaging from qualitative pattern recognition toward objective, reproducible and data-driven characterisation of disease. Quantitative imaging converts tracer distribution into measurable biological metrics, ranging from simple region-of-interest count ratios to standardised uptake values and kinetic parameters. Radiomics builds on this foundation by extracting high-dimensional features describing intensity, shape, texture and spatial heterogeneity, revealing image information not appreciable to the human eye. AI, through machine learning and deep learning approaches, integrates quantitative and radiomic data with clinical variables to automate segmentation, enhance reconstruction, support classification, and enable predictive modelling. Together, these tools offer potential to improve differentiation of infection from sterile inflammation, quantify disease burden, monitor therapy response, and standardise interpretation in complex scenarios. Quantitative accuracy and radiomic stability remain highly dependent on acquisition, reconstruction and processing parameters. AI-driven image enhancement and denoising may improve visual appearance while altering voxel statistics, with downstream effects on quantitative metrics and texture features. Variability in feature definitions, segmentation methods and analysis pipelines further limits reproducibility. Consequently, harmonisation, standardisation, transparent validation and physics-informed AI models are essential.</div></div><div>Nuclear medicine infection imaging has traditionally relied on semantic visual interpretation supported by simple semi-quantitative indices. While effective, this paradigm is limited by observer dependence, restricted sensitivity to subtle or diffuse disease, and difficulty in standardising interpretation across centres. Advances in quantitative imaging, radiomics and artificial intelligence (AI) are reshaping this landscape. These complementary domains, collectively conceptualised as <em>computomics</em>, extend infection imaging from qualitative pattern recognition toward objective, reproducible and data-driven characterisation of disease. Quantitative imaging converts tracer distribution into measurable biological metrics, ranging from simple region-of-interest count ratios to standardised uptake values and kinetic parameters. Radiomics builds on this foundation by extracting high-dimensional features describing intensity, shape, texture and spatial heterogeneity, revealing image information not appreciable to the human eye. AI, through machine learning and deep learning approaches, integrates quantitative and radiomic data with clinical variables to automate segmentation, enhance reconstruction, support classification, and enable predictive modelling. Together, these tools offer potential to improve differentiation of infection from sterile inflammation, quantify disease burden, monitor therapy response, and standardise interpretation in complex scenarios. Quantitative accuracy and radiomic stability remain highly dependent on acquisition, reconstruction and processing parameters. AI-driven image enhancement and denoising may improve visual appearance while altering voxel statistics, with downstream effects on quantitative metrics and texture features. Variability in feature definitions, segmentation methods and analysis pipelines further limits reproducibility. Consequently, harmonisation, standardisation, transparent validation and physics-informed AI models are essential.</div>","PeriodicalId":21643,"journal":{"name":"Seminars in nuclear medicine","volume":"56 3","pages":"Pages 414-429"},"PeriodicalIF":6.6000,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in nuclear medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0001299826000449","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/13 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

Abstract

Nuclear medicine infection imaging has traditionally relied on semantic visual interpretation supported by simple semi-quantitative indices. While effective, this paradigm is limited by observer dependence, restricted sensitivity to subtle or diffuse disease, and difficulty in standardising interpretation across centres. Advances in quantitative imaging, radiomics and artificial intelligence (AI) are reshaping this landscape. These complementary domains, collectively conceptualised as computomics, extend infection imaging from qualitative pattern recognition toward objective, reproducible and data-driven characterisation of disease. Quantitative imaging converts tracer distribution into measurable biological metrics, ranging from simple region-of-interest count ratios to standardised uptake values and kinetic parameters. Radiomics builds on this foundation by extracting high-dimensional features describing intensity, shape, texture and spatial heterogeneity, revealing image information not appreciable to the human eye. AI, through machine learning and deep learning approaches, integrates quantitative and radiomic data with clinical variables to automate segmentation, enhance reconstruction, support classification, and enable predictive modelling. Together, these tools offer potential to improve differentiation of infection from sterile inflammation, quantify disease burden, monitor therapy response, and standardise interpretation in complex scenarios. Quantitative accuracy and radiomic stability remain highly dependent on acquisition, reconstruction and processing parameters. AI-driven image enhancement and denoising may improve visual appearance while altering voxel statistics, with downstream effects on quantitative metrics and texture features. Variability in feature definitions, segmentation methods and analysis pipelines further limits reproducibility. Consequently, harmonisation, standardisation, transparent validation and physics-informed AI models are essential.
Nuclear medicine infection imaging has traditionally relied on semantic visual interpretation supported by simple semi-quantitative indices. While effective, this paradigm is limited by observer dependence, restricted sensitivity to subtle or diffuse disease, and difficulty in standardising interpretation across centres. Advances in quantitative imaging, radiomics and artificial intelligence (AI) are reshaping this landscape. These complementary domains, collectively conceptualised as computomics, extend infection imaging from qualitative pattern recognition toward objective, reproducible and data-driven characterisation of disease. Quantitative imaging converts tracer distribution into measurable biological metrics, ranging from simple region-of-interest count ratios to standardised uptake values and kinetic parameters. Radiomics builds on this foundation by extracting high-dimensional features describing intensity, shape, texture and spatial heterogeneity, revealing image information not appreciable to the human eye. AI, through machine learning and deep learning approaches, integrates quantitative and radiomic data with clinical variables to automate segmentation, enhance reconstruction, support classification, and enable predictive modelling. Together, these tools offer potential to improve differentiation of infection from sterile inflammation, quantify disease burden, monitor therapy response, and standardise interpretation in complex scenarios. Quantitative accuracy and radiomic stability remain highly dependent on acquisition, reconstruction and processing parameters. AI-driven image enhancement and denoising may improve visual appearance while altering voxel statistics, with downstream effects on quantitative metrics and texture features. Variability in feature definitions, segmentation methods and analysis pipelines further limits reproducibility. Consequently, harmonisation, standardisation, transparent validation and physics-informed AI models are essential.
量化、放射组学和人工智能在感染成像中的应用:核医学的现状和未来方向。
核医学感染成像传统上依赖于简单的半定量指标支持的语义视觉解释。虽然有效,但这种模式受到观察者依赖性、对细微或弥漫性疾病的敏感性有限以及跨中心标准化解释的困难等因素的限制。定量成像、放射组学和人工智能(AI)的进步正在重塑这一格局。这些互补的领域统称为计算组学,将感染成像从定性模式识别扩展到客观、可重复和数据驱动的疾病表征。定量成像将示踪剂分布转化为可测量的生物指标,范围从简单的感兴趣区域计数比率到标准化摄取值和动力学参数。放射组学在此基础上提取描述强度、形状、纹理和空间异质性的高维特征,揭示人眼无法感知的图像信息。人工智能通过机器学习和深度学习方法,将定量和放射学数据与临床变量相结合,实现自动分割,增强重建,支持分类,并实现预测建模。总之,这些工具有可能改善感染与无菌炎症的区分,量化疾病负担,监测治疗反应,并在复杂情况下标准化解释。定量精度和放射性稳定性仍然高度依赖于采集、重建和处理参数。人工智能驱动的图像增强和去噪可以改善视觉外观,同时改变体素统计,对定量指标和纹理特征产生下游影响。特征定义、分割方法和分析管道的可变性进一步限制了再现性。因此,协调、标准化、透明验证和基于物理的人工智能模型至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Seminars in nuclear medicine
Seminars in nuclear medicine 医学-核医学
CiteScore
9.80
自引率
6.10%
发文量
86
审稿时长
14 days
期刊介绍: Seminars in Nuclear Medicine is the leading review journal in nuclear medicine. Each issue brings you expert reviews and commentary on a single topic as selected by the Editors. The journal contains extensive coverage of the field of nuclear medicine, including PET, SPECT, and other molecular imaging studies, and related imaging studies. Full-color illustrations are used throughout to highlight important findings. Seminars is included in PubMed/Medline, Thomson/ISI, and other major scientific indexes.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书